Neoadjuvant hormonal therapy in prostate cancer - impact of PSA level before radiotherapy

Abstrakt

To retrospectively investigate the impact of prostate specific antigen (PSA) level after neoadjuvant androgen-deprivation therapy (ADT) on biochemical relapse-free survival in patients with prostate cancer who received radical radiotherapy (RT).

Klíčová slova

• androgen-deprivation therapy
• neoadjuvant hormonotherapy
• prostate cancer
• PSA
• radiotherapy